United Health Products, Inc. (UEEC) stock: key figures, P/E, revenue and dividend

Health Care · United States · ISIN US91059D1000

Price
0.04 USD
Market cap
10.51 m USD
P/E (2026)
–
P/S (2026)
–
Dividend yield
0.00 %
Net margin
–
Return on equity (ROE)
–
Return on assets (ROA)
–

United Health Products, Inc. financials

Fiscal year2025
Revenue0.00 USD
Operating income-2.26 m USD
EBIT-2.56 m USD
Net income-2.67 m USD
Diluted EPS – continuing operations-0.01 USD

Full history since 2005, charts and your own formulas

This page shows the last two fiscal years. After free sign-up you get the full income statement, balance sheet and cash flow, price and dividend charts, your own formula metrics and a stock screener covering more than 8,000 companies.

About United Health Products, Inc.

United Health Products, Inc. develops, manufactures, and markets hemostatic gauze products for the healthcare and wound care sectors in the United States. The company offers CelluSTAT hemostatic gauze products to absorb exudate/drainage from superficial wounds, as well as helps in controlling bleeding. It serves hospitals and surgery centers, clinics and physicians, military medical care providers, hemodialysis centers, nursing homes and assisted living, and veterinary hospitals; and EMS, fire departments, and other first responders, as well as dental, oral, and maxillofacial surgery offices. The company was formerly known as United EcoEnergy Corp. and changed its name to United Health Products, Inc. in September 2010. The company was incorporated in 1997 and is headquartered in Mount Laurel, New Jersey.

More stocks

All stocks →

Not investment advice. All data without warranty, price as of 12.11.2026. Details in the risk notice.